Overview
Obstructive sleep apnea (OSA) is a medical condition which impedes the airflow through the pharyngeal airways resulting in interrupted breathing during sleep. Sleep apnea occurs due to a collapse of the tissue walls around upper airways that causes irregular shallow breathing (hypopnea) or discontinued breathing (apnea). OSA is the most common type of sleep apnea that affects over 18 million Americans with 2-4% of those going undiagnosed. 25% of middle-aged men and 9% of middle-aged women suffer from OSA. Undiagnosed or untreated OSA can cause headaches, short-term memory, stroke, insomnia, daytime fatigue, cognitive problems and could be fatal for those with cardiovascular disorders. Although there are some surgical and non-surgical treatments for OSA, there is a need for a state-of-the-art solution which can forestall the occurrence of the apnea episodes.
Technology
The proposed solution is a light-weight device that gathers data from the patient’s neck, predicts the occurrence of an apnea episode and makes a therapeutic intervention so the apnea event is preempted from happening. The device uses a multichannel photoplethysmography (PPG) sensor with photodiodes and two pairs of red and infrared light emitting diodes. From the PPG’s waveform three different biomarkers are identified (heart rate, respiration rate and oxygen saturation level) so the prediction can be made with a robust set of body signals. The prediction algorithm uses reliable machine learning techniques to estimate the likelihood of an apnea episode occurrence so the therapeutic intervention.
Research Interests
由于技术保密工作限制,技术信息无法完全展现,请通过邮箱或短信联系我们,获取更多技术资料。
oxygen saturation level
pharyngeal airways resulting
middle-aged women suffer
irregular shallow breathing
apnea episode occurrence